La Chaux-de-Fonds, Switzerland

Thierry Monney

USPTO Granted Patents = 2 

Average Co-Inventor Count = 8.6

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Thierry Monney: Innovator in Bispecific Antibodies

Introduction

Thierry Monney is a notable inventor based in La Chaux-de-Fonds, Switzerland. He has made significant contributions to the field of immunology, particularly in the development of bispecific antibodies. With a total of 2 patents, his work focuses on innovative solutions for treating various diseases.

Latest Patents

Monney's latest patents include groundbreaking advancements in bispecific heterodimeric immunoglobulins. One patent details the creation of antibodies that target both the human CD47 and CD38 antigens. This novel class of antibodies is designed to treat autoimmune and proliferative diseases, including cancers such as hematologic malignancies and solid tumors. Another patent involves antibodies that specifically bind to human IL1RAP, which may also interact with cynomolgus monkey and mouse IL1RAP. These antibodies have potential applications in diagnosing and treating human diseases.

Career Highlights

Throughout his career, Thierry Monney has worked with several prominent companies in the biotechnology sector. Notably, he has been associated with Igi Therapeutics and Ichnos Sciences. His expertise in immunology and antibody development has positioned him as a key figure in the advancement of therapeutic solutions.

Collaborations

Monney has collaborated with various professionals in his field, including Marie-Agnes Doucey and Jeremy Loyau. These partnerships have contributed to the successful development of his innovative patents.

Conclusion

Thierry Monney's contributions to the field of bispecific antibodies highlight his role as an influential inventor. His work continues to pave the way for new treatments in immunology and oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…